FDA warns of birth defects with Topamax


SymbolPriceChangeJNJ60.54-0.51Chart for Johnson  Johnson Common StockVVUS6.40-0.65Chart for VIVUS, Inc.{“s” : “jnj,vvus”,”k” : “a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00″,”o” : “”,”j” : “”}

WASHINGTON (AP) — The Food and Drug Administration is warning women of child-bearing age that the epilepsy drug Topamax can increase the risk of birth defects around the mouth.

Regulators said Friday that data collected from a registry of pregnant women showed a higher rate of cleft lip and cleft palate in babies whose mothers were taking the drug during the first trimester. Infants who were exposed to the drug had a 1.4 percent rate of mouth defects, which was more

Read More from the Article Source: Full Article


Filed under Financial and tagged , , , , , .

Leave a Reply